Cargando…

The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study

The aim of this randomized double-blind placebo-controlled study was to evaluate the effectiveness and safety of multi-strain probiotic in adults with diarrhea-predominant irritable bowel syndrome (IBS-D). The patients were randomized to receive a mixture of Lactobacillus, Bifidobacterium, and Strep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skrzydło-Radomańska, Barbara, Prozorow-Król, Beata, Cichoż-Lach, Halina, Majsiak, Emilia, Bierła, Joanna Beata, Kanarek, Ewelina, Sowińska, Agnieszka, Cukrowska, Bożena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996889/ https://www.ncbi.nlm.nih.gov/pubmed/33652763 http://dx.doi.org/10.3390/nu13030756

Ejemplares similares

The Occurrence of Gluten-Related Antibodies, Sensitization to Selected Food Allergens, and Antibodies against Intrinsic Factor in Adult Patients with Diarrhea-Predominant Irritable Bowel Syndrome
por: Bierła, Joanna B., et al.
Publicado: (2023)

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2020)

The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2023)

Hepatomegaly, weight loss and general malaise – the first manifestations of primary systemic amyloidosis
por: Cichoż-Lach, Halina, et al.
Publicado: (2014)

A rare case of skin blistering and esophageal stenosis in the course of epidermolysis bullosa - case report and literature review
por: Michalak, Agata, et al.
Publicado: (2018)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

How to Recognize and Treat Small Intestinal Bacterial Overgrowth?
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2022)

IgE-Dependent Allergy in Patients with Celiac Disease: A Systematic Review
por: Majsiak, Emilia, et al.
Publicado: (2023)

Evaluation of the Usefulness of a Serological Test for Diagnosis of Celiac Disease Simultaneously Detecting Specific Antibodies and Total IgA
por: Majsiak, Emilia, et al.
Publicado: (2022)

Intestinal epithelium, intraepithelial lymphocytes and the gut microbiota - Key players in the pathogenesis of celiac disease
por: Cukrowska, Bożena, et al.
Publicado: (2017)

The Effectiveness of Probiotic Lactobacillus rhamnosus and Lactobacillus casei Strains in Children with Atopic Dermatitis and Cow’s Milk Protein Allergy: A Multicenter, Randomized, Double Blind, Placebo Controlled Study
por: Cukrowska, Bożena, et al.
Publicado: (2021)

The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review
por: Daniluk, Jaroslaw, et al.
Publicado: (2022)

Impact of Obesity on the Course of Management of Inflammatory Bowel Disease—A Review
por: Michalak, Agata, et al.
Publicado: (2022)

Refractory ascites—the contemporary view on pathogenesis and therapy
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2019)

Wilson’s Disease: An Update on the Diagnostic Workup and Management
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2021)

The Opinion of Polish Coeliac Patients on the Knowledge of Medical Professionals and Support Groups about Coeliac Disease—A Pilot Study
por: Majsiak, Emilia, et al.
Publicado: (2023)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)

The Therapeutic Effect of a Multistrain Probiotic on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study
por: Lee, Seok-Hoon, et al.
Publicado: (2018)

Allergic March in Children: The Significance of Precision Allergy Molecular Diagnosis (PAMD@) in Predicting Atopy Development and Planning Allergen-Specific Immunotherapy
por: Knyziak-Mędrzycka, Izabela, et al.
Publicado: (2023)

Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik
por: Pietrzak, Anna, et al.
Publicado: (2018)

Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights
por: Sciumè, Giusi Desirè, et al.
Publicado: (2023)

Effect of Probiotic Administration Immediately and 1 Month after Colonoscopy in Diarrhea-predominant Irritable Bowel Syndrome Patients
por: Khodadoostan, Mahsa, et al.
Publicado: (2018)

Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update
por: Andrews, Christopher N, et al.
Publicado: (2019)

Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of a Randomized Double-Blind Placebo-Controlled Trial
por: Gąsiorowska, Anita, et al.
Publicado: (2022)

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Sobolewska-Włodarczyk, Aleksandra, et al.
Publicado: (2016)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
por: Li, Pingping, et al.
Publicado: (2020)

A Rare Case of Upper Gastrointestinal Bleeding: Osler-Weber-Rendu Syndrome
por: Jargielo, Anna, et al.
Publicado: (2022)

Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome
por: BOUSABA, J., et al.
Publicado: (2023)

The Impact of a CMV Infection on the Expression of Selected Immunological Parameters in Liver Tissue in Children with Biliary Atresia
por: Janowska, Maria, et al.
Publicado: (2022)

Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2023)

Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea: A randomized controlled trial
por: Zheng, Hui, et al.
Publicado: (2016)

Dysregulation of GABAergic Signalling Contributes in the Pathogenesis of Diarrhea-predominant Irritable Bowel Syndrome
por: Aggarwal, Surbhi, et al.
Publicado: (2018)

Serum-derived bovine immunoglobulin for children with diarrhea-predominant irritable bowel syndrome
por: Arrouk, Rami, et al.
Publicado: (2018)

Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome
por: Katsumata, Ryo, et al.
Publicado: (2017)

Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
por: Mei, Lijun, et al.
Publicado: (2021)

Efficacy and dose response of Lactiplantibacillus plantarum in diarrhea-predominant irritable bowel syndrome
por: Martoni, Christopher J, et al.
Publicado: (2023)

The impact of symptoms on quality of life before and after diagnosis of coeliac disease: the results from a Polish population survey and comparison with the results from the United Kingdom
por: Majsiak, Emilia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_645qk2plngg3f8r3mbo7c4egi3